Media Contacts:
Rachel Yarmolinsky
Director of Media Relations
Phone: 212-543-5353
Dacia Morris
Public Information Officer
Phone: (212) 543-5421
Fax: (212) 543-5220
NYS Psychiatric Institute at
Columbia University Medical Center
1051 Riverside Drive, Unit 30
New York, NY 10032
For all types of diseases, the development of new drugs is a story of many failures and very few successes. Of the compounds that enter phase I testing, only 15 percent are eventually approved by the FDA. For psychiatric and neurologic disorders, the success rate is even lower – about 8 percent – and compounds tend to fail late in development after hundreds of millions of dollars have already been spent.
Read more at http://www.cumc.columbia.edu/news-room/2012/11/08/new-fast-fail-initiative-takes-aim-at-psychosis/#.UJ1Pu2-HIud
